• Oridonin Inhibits Esophageal Cancer via TLR4/NF-κB/NLRP3 Pat

  2026-05-05

  Peng et al. (2025) demonstrate that oridonin suppresses esophageal cancer progression by inhibiting the TLR4/NF-κB/NLRP3 inflammasome pathway in a murine model. This mechanistic insight advances the understanding of inflammation-driven carcinogenesis and highlights anti-inflammatory targeting as a preclinical strategy for esophageal cancer intervention.

• Toremifene Citrate: Applied Workflows in Estrogen Receptor R

  2026-05-04

  Toremifene Citrate empowers breast cancer and hormone receptor research with quantifiable, reproducible modulation of estrogen receptor signaling. This guide delivers protocol-driven enhancements, practical troubleshooting, and comparative insights—enabling researchers to maximize data fidelity using a rigorously validated oral selective estrogen receptor modulator.

• One-step TUNEL Cy3 Apoptosis Detection Kit: Precision TdT La

  2026-05-04

  The One-step TUNEL Cy3 Apoptosis Detection Kit streamlines high-sensitivity TdT-mediated DNA fragmentation assays in both tissue sections and cultured cells. Its robust workflow and Cy3 fluorescence enable researchers to dissect apoptosis mechanisms with reproducibility and clarity, empowering advanced oncology and neurobiology studies.

• BMS-777607 (SKU A5703): Reliable c-Met Inhibitor for Assay P

  2026-05-03

  This article addresses real laboratory challenges in cell viability, proliferation, and differentiation assays, highlighting how BMS-777607 (SKU A5703) provides robust, data-backed solutions. Drawing on up-to-date literature, we examine protocol optimization, data interpretation, and product reliability, guiding biomedical researchers to reproducible results with APExBIO’s BMS-777607.

• Cy3 TSA Fluorescence System Kit: Amplifying Detection in IHC

  2026-05-02

  The Cy3 TSA Fluorescence System Kit empowers researchers to sensitively detect low-abundance proteins and nucleic acids in tissue and cell assays, revolutionizing workflows in immunohistochemistry and beyond. Its robust signal amplification and compatibility with standard microscopy make it a versatile solution for high-impact molecular discovery.

• Applied Actinomycin D: Protocols, Troubleshooting, and Vascu

  2026-05-01

  Actinomycin D (ActD) is a gold-standard tool for transcriptional inhibition and apoptosis induction in cancer and cell biology research. This article delivers actionable protocol enhancements, real-world troubleshooting, and translational applications rooted in the latest evidence—including nucleolar stress modeling for vascular disease. Discover how to optimize your assays with data-driven parameters and leverage APExBIO’s high-purity ActD for robust, reproducible outcomes.

• Neuromedin S (rat): Protocols and QC for GPCR Signaling Rese

  2026-05-01

  Neuromedin S (rat) is a rigorously defined endogenous peptide agonist for neuromedin U receptor activation in rat-based GPCR/G protein signaling research. It addresses the need for reproducible, validated ligands in studies of energy homeostasis regulation and stress response. Not for diagnostic or therapeutic use; optimal results require strict adherence to solubility, handling, and storage protocols.

• Trichostatin A (TSA): Precision Epigenetic Modulation in Can

  2026-04-30

  Trichostatin A (TSA) from APExBIO empowers cancer researchers to dissect epigenetic regulation at unprecedented resolution, enabling robust inhibition of breast cancer cell proliferation and chromatin remodeling. This guide delivers actionable workflows, troubleshooting strategies, and practical insights that bridge mechanistic breakthroughs—like the HDAC1-mediated immune evasion axis—into high-fidelity experimental design.

• Busulfan as a DNA Alkylating Agent: Applied Workflows & Insi

  2026-04-30

  Busulfan empowers precise modeling of germ cell depletion and senescence induction across cellular and animal systems. This guide translates recent genetic tracing innovations into actionable protocols and troubleshooting strategies to maximize reproducibility with APExBIO's Busulfan.

• Verbascoside in Neuroinflammation: PKC/NF-κB Inhibition Beyo

  2026-04-29

  Explore how Verbascoside, a potent PKC/NF-κB inhibitor, enables advanced neuroinflammation and osteoclastogenesis research. This article uniquely bridges cellular signaling with neuroimmune mechanisms, offering deeper insights for innovative experimental designs.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-04-29

  This study demonstrates that naturally occurring angiotensin peptides, including fragments like Angiotensin 1/2 (5-7), potentiate the binding of the SARS-CoV-2 spike protein to AXL, a viral entry receptor. These insights reveal new mechanistic intersections between the renin-angiotensin system and COVID-19 pathogenesis, suggesting implications for hypertension research and antiviral strategies.

• Bovine Insulin: Protocols and Troubleshooting for Cell Cultu

  2026-04-28

  Bovine insulin from APExBIO powers high-precision cell culture and metabolic research, uniquely supporting robust proliferation and signaling assays. This guide translates advanced findings on insulin signaling into actionable workflows, troubleshooting tactics, and optimized protocol parameters for reproducible results.

• Bortezomib (PS-341): Evidence-Based Proteasome Inhibition in

  2026-04-28

  Bortezomib (PS-341) is a clinically approved, reversible 20S proteasome inhibitor with robust activity in apoptosis assays and multiple myeloma research. Supplied by APExBIO, it offers precise, reproducible benchmarks for cellular and animal models. Its selectivity, potency, and established usage protocols make it a cornerstone for proteasome-regulated cellular process studies.

• Dextrose (D-glucose): Precision Tool for Glucose Metabolism

  2026-04-27

  Dextrose (D-glucose) from APExBIO is the gold-standard substrate for dissecting metabolic adaptation in hypoxic and immunosuppressive environments. This article delivers practical protocols, data-driven troubleshooting, and cross-resource insights for advanced glucose metabolism and cell culture studies.

• iPSC-Based Multimodal Platform for Cystic Fibrosis Drug Test

  2026-04-27

  The referenced study introduces a robust multimodal platform using induced pluripotent stem cell (iPSC)-derived airway epithelial cells to model cystic fibrosis (CF) and assess responses to CFTR modulators. This innovation enables functional, genotype-specific in vitro drug testing for both common and rare CFTR variants, supporting the acceleration of precision therapeutics development.

7783 records 20/519 page Previous Next First page 上5页 1617181920 下5页 Last page